Consequently, we anticipated that CPT1A‐IL‐10 axis, bridging cellular metabolism and immunological function in macrophages, may pave the way for new approaches to address inflammatory diseases, particularly ALI/ARDS, where effective treatments are currently lacking. The gene discussed is IL10; the disease is acute respiratory distress syndrome.